These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 22487225)

  • 1. Unusual substrate underlying Brugada syndrome and early repolarization syndrome revealed in unusual circadian and seasonal patterns.
    Schwartz BG; Kloner RA; Cannom DS
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):764-5. PubMed ID: 22487225
    [No Abstract]   [Full Text] [Related]  

  • 2. Circadian and seasonal variations of ventricular tachyarrhythmias in patients with early repolarization syndrome and Brugada syndrome: analysis of patients with implantable cardioverter defibrillator.
    Kim SH; Nam GB; Baek S; Choi HO; Kim KH; Choi KJ; Joung B; Pak HN; Lee MH; Kim SS; Park SJ; On YK; Kim JS; Oh IY; Choi EK; Oh S; Choi YS; Choi JI; Park SW; Kim YH; Lee MY; Lim HE; Lee YS; Cho Y; Kim J; Lee DI; Cho DK; Kim YH
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):757-63. PubMed ID: 22353358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wearable cardioverter-defibrillator as a bridge to implantable cardioverter-defibrillator treatment.
    Technol Eval Cent Assess Program Exec Summ; 2010 Nov; 25(2):1-5. PubMed ID: 21638938
    [No Abstract]   [Full Text] [Related]  

  • 4. Circadian variations in ST-segment elevation surrounding the spontaneous onset of ventricular fibrillation in Brugada syndrome.
    Kaneko Y; Nakajima T; Ota M; Kurabayashi M
    J Cardiovasc Electrophysiol; 2012 Jun; 23(6):664-5. PubMed ID: 22004590
    [No Abstract]   [Full Text] [Related]  

  • 5. Abdominal submuscular implant of subcutaneous implantable cardioverter-defibrillator in a young child.
    Kwok SY; Yam N; Lun KS; Chen RH; Au TW; Yung TC
    Europace; 2018 Sep; 20(FI2):f248. PubMed ID: 29401320
    [No Abstract]   [Full Text] [Related]  

  • 6. Ventricular fibrillation storm in a child.
    Einbinder T; Lowenthal A; Fogelman R
    Europace; 2014 Nov; 16(11):1654. PubMed ID: 25344961
    [No Abstract]   [Full Text] [Related]  

  • 7. Radiofrequency Ablation of Asymptomatic Brugada Syndrome: Don't Go Burning My Heart.
    Viskin S
    Circulation; 2018 May; 137(18):1883-1884. PubMed ID: 29530885
    [No Abstract]   [Full Text] [Related]  

  • 8. Pursuing the "Holy Grail".
    Dickfeld T
    Circ Cardiovasc Imaging; 2012 Mar; 5(2):167-70. PubMed ID: 22438421
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of Ventricular Arrhythmias and Sudden Cardiac Death Risk Associated With Cardiac Channelopathies.
    Al-Khatib SM; Stevenson WG
    JAMA Cardiol; 2018 Aug; 3(8):775-776. PubMed ID: 29955839
    [No Abstract]   [Full Text] [Related]  

  • 10. Current review of Brugada syndrome: from epidemiology to treatment.
    Khan A; Mittal S; Sherrid MV
    Anadolu Kardiyol Derg; 2009 Dec; 9 Suppl 2():12-6. PubMed ID: 20089482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
    Proclemer A; Ghidina M
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):320-3. PubMed ID: 17443096
    [No Abstract]   [Full Text] [Related]  

  • 12. Antitachycardia pacing therapy for the successful treatment of lead fracture.
    Bhimani AA; Deeprasertkul P; Nannapaneni N; Carayannopoulos GN
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):228-9. PubMed ID: 25354719
    [No Abstract]   [Full Text] [Related]  

  • 13. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia in patients with an implantable defibrillator warrants catheter ablation.
    Kuck KH
    Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):713-20; discussion 720. PubMed ID: 20009082
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary prevention of sudden cardiac death: one step forwards and one step backwards.
    Cain ME
    Nat Clin Pract Cardiovasc Med; 2006 Mar; 3(3):115. PubMed ID: 16505838
    [No Abstract]   [Full Text] [Related]  

  • 15. Device therapy: High-zone programming of ICDs reduces inappropriate shocks.
    Huynh K
    Nat Rev Cardiol; 2015 Apr; 12(4):193. PubMed ID: 25732361
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence of early repolarization pattern in inferolateral leads in patients with Brugada syndrome.
    Letsas KP; Sacher F; Probst V; Weber R; Knecht S; Kalusche D; Haïssaguerre M; Arentz T
    Heart Rhythm; 2008 Dec; 5(12):1685-9. PubMed ID: 19084806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letter by Obeyesekere regarding article, "Combined cardiac magnetic resonance imaging and C-reactive protein levels identify a cohort at low risk for defibrillator firings and death".
    Obeyesekere MN
    Circ Cardiovasc Imaging; 2012 Jul; 5(4):e52; author reply e53. PubMed ID: 22811421
    [No Abstract]   [Full Text] [Related]  

  • 18. Ventricular arrhythmias and sudden cardiac death.
    John RM; Tedrow UB; Koplan BA; Albert CM; Epstein LM; Sweeney MO; Miller AL; Michaud GF; Stevenson WG
    Lancet; 2012 Oct; 380(9852):1520-9. PubMed ID: 23101719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia ablation versus drugs for preventing ICD shocks: role of adjuvant antiarrhythmic drug therapy.
    Patel C; Yan GX; Kocovic D; Kowey PR
    Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):705-11; discussion 712. PubMed ID: 20009081
    [No Abstract]   [Full Text] [Related]  

  • 20. [Primary and secondary prevention of sudden cardiac death].
    Janion M; Sadowski M; Sielski J; Janion-Sadowska A
    Pol Arch Med Wewn; 2006 Jan; 115(1):65-72. PubMed ID: 17278788
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.